125 related articles for article (PubMed ID: 2139461)
1. Characterization of the binding of radioiodinated hybrid recombinant IFN-alpha A/D to murine and human lymphoid cell lines.
Faltynek CR; Princler GL; Schwabe M; Shata MT; Lewis GK; Kamin-Lewis RM
J Interferon Res; 1990 Feb; 10(1):55-64. PubMed ID: 2139461
[TBL] [Abstract][Full Text] [Related]
2. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
[TBL] [Abstract][Full Text] [Related]
3. Binding of human recombinant 125I-interferon gamma to receptors on human cells.
Littman SJ; Faltynek CR; Baglioni C
J Biol Chem; 1985 Jan; 260(2):1191-5. PubMed ID: 3155725
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the human type I interferon receptor by ligand blotting.
Schwabe M; Princler GL; Faltynek CR
Eur J Immunol; 1988 Dec; 18(12):2009-14. PubMed ID: 2975600
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity.
Rosenblum MG; Yung WK; Kelleher PJ; Ruzicka F; Steck PA; Borden EC
J Interferon Res; 1990 Apr; 10(2):141-51. PubMed ID: 2140395
[TBL] [Abstract][Full Text] [Related]
6. Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta.
Yoshida R; Murray HW; Nathan CF
J Exp Med; 1988 Mar; 167(3):1171-85. PubMed ID: 2965208
[TBL] [Abstract][Full Text] [Related]
7. The characteristics of binding of human recombinant interferon-gamma to its receptor on human monocytes and human monocyte-like cell lines.
Finbloom DS; Hoover DL; Wahl LM
J Immunol; 1985 Jul; 135(1):300-5. PubMed ID: 3158703
[TBL] [Abstract][Full Text] [Related]
8. Differential modulation of two interferon-alpha binding proteins on a human lymphoblastoid cell line.
Faltynek CR; Princler GL; Schwabe M
Cytokine; 1991 Nov; 3(6):627-35. PubMed ID: 1838703
[TBL] [Abstract][Full Text] [Related]
9. Binding of recombinant-produced interferon beta ser to human lymphoblastoid cells. Evidence for two binding domains.
Ruzicka FJ; Jach ME; Borden EC
J Biol Chem; 1987 Nov; 262(33):16142-9. PubMed ID: 2960673
[TBL] [Abstract][Full Text] [Related]
10. Lectins modulate the internalization of recombinant interferon-alpha A and the induction of 2',5'-oligo(A) synthetase.
Faltynek CR; Princler GL; Ruscetti FW; Birchenall-Sparks M
J Biol Chem; 1988 May; 263(15):7112-7. PubMed ID: 2966801
[TBL] [Abstract][Full Text] [Related]
11. Characterization of receptors for human recombinant interferon-gamma in human cells.
Akinaga S; Gomi K; Oka T; Morimoto M
J Pharmacobiodyn; 1987 Jun; 10(6):272-9. PubMed ID: 2959767
[TBL] [Abstract][Full Text] [Related]
12. Variation in the binding of 125I-labeled interferon-beta ser to cellular receptors during growth of human renal and bladder carcinoma cells in vitro.
Ruzicka FJ; Schmid SM; Groveman DS; Cummings KB; Borden EC
Cancer Res; 1987 Sep; 47(17):4582-9. PubMed ID: 2957045
[TBL] [Abstract][Full Text] [Related]
13. Binding of unglycosylated and glycosylated human recombinant interferon-gamma to cellular receptors.
Littman SJ; Devos R; Baglioni C
J Interferon Res; 1985; 5(3):471-6. PubMed ID: 2932505
[TBL] [Abstract][Full Text] [Related]
14. Radiolabeling of the interferon-alpha receptor.
Langer JA
Biochem Biophys Res Commun; 1988 Dec; 157(3):1264-70. PubMed ID: 2974697
[TBL] [Abstract][Full Text] [Related]
15. Specific high-affinity receptors for interferon-gamma on mouse bone marrow-derived mast cells: inhibitory effect of interferon-gamma on mast cell precursors.
Nafziger J; Arock M; Guillosson JJ; Wietzerbin J
Eur J Immunol; 1990 Jan; 20(1):113-7. PubMed ID: 2137779
[TBL] [Abstract][Full Text] [Related]
16. Binding of 125I-labeled recombinant beta interferon (IFN-beta Ser17) to human cells.
O'Rourke EC; Drummond RJ; Creasey AA
Mol Cell Biol; 1984 Dec; 4(12):2745-9. PubMed ID: 6441889
[TBL] [Abstract][Full Text] [Related]
17. 125I-labelled human interferons alpha, beta and gamma: comparative receptor-binding data.
Merlin G; Falcoff E; Aguet M
J Gen Virol; 1985 May; 66 ( Pt 5)():1149-52. PubMed ID: 3158718
[TBL] [Abstract][Full Text] [Related]
18. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
Brunda MJ; Rosenbaum D
Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
[TBL] [Abstract][Full Text] [Related]
19. Serum-induced suppression of interferon (IFN) activity. Lack of evidence for the presence of specific autoantibodies to IFN-alpha in normal human sera.
Hansen MB; Svenson M; Bendtzen K
Clin Exp Immunol; 1992 Jun; 88(3):559-62. PubMed ID: 1606741
[TBL] [Abstract][Full Text] [Related]
20. High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.
Ross C; Svenson M; Hansen MB; Vejlsgaard GL; Bendtzen K
J Clin Invest; 1995 May; 95(5):1974-8. PubMed ID: 7738163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
